Related Experiment Videos
Health Technology Assessment Lifecycle Concepts: A Scoping Review Outlining the Change in Policies to Manage
Jelle Stoelinga1, Carla E Hollak2, Lonneke Timmers3
1Division of Pharmacoepidemiology and Clinical Pharmacy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Objective:
Health Technology Assessment (HTA) agencies aim to evaluate the value of a health technology at specific points in its lifecycle. However, much remains unclear about how HTA lifecycle concepts are employed and which stakeholders are involved. We aimed to clarify the use of HTA lifecycle concepts and how they relate to each other to facilitate implementation and outline next steps for policy development.
Methods:
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews, we analyzed scientific and policy literature on HTA lifecycle concepts for medicines in the PubMed, Embase, and Overton databases. Data were extracted using standardized forms and analyzed both descriptively and using a directed qualitative content analysis.
Results:
We identified 60 scientific studies and 5 policy documents covering five different HTA lifecycle concepts. Health Technology Reassessment (HTR), Health Technology Management (HTM), and Lifecycle HTA (LC-HTA) were most frequently described in scientific literature (respectively, 22, 17, and 10 studies). We found that the activities of these concepts partially overlapped, but often differed in their content. In addition to activities identified in HTR and HTM, LC- HTA included pre-market entry activities that facilitate planning of risk mitigation strategies.
Conclusions:
The anticipatory nature and content of activities within LC-HTA led to it emerging as the most appropriate for addressing the clinical and financial risks to the initial reimbursement decisions for contemporary medicines. Both capacity building and further development of triaging for risk-based reimbursement pathway assignment can aid in the implementation of LC-HTA in practice.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:30Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Drug Products: Biologics, Biosimilars and Interchangeables